echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > PHEXCOM successfully completed the audit of WuXi AppTec Suzhou GLP factory

    PHEXCOM successfully completed the audit of WuXi AppTec Suzhou GLP factory

    • Last Update: 2021-07-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On March 25-26, 2021, PHEXCOM audit expert Ms.
    Zhang conducted an on-site audit of WuXi AppTec Suzhou Plant
    .

    WuXi AppTec Suzhou was established in October 2006.
    It is a wholly-owned subsidiary of WuXi AppTec.
    The facility covers an area of ​​more than 30,000 square meters.
    It currently provides genotoxicity testing services that comply with GLP standards to global customers and has passed the AAALAC international Certification; GLP certification of SFDA; GLP certification of European OECD; and drug safety evaluation center that has passed comprehensive qualification certification
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.